Literature DB >> 9253965

Glial cell involvement in vascular occlusion of diabetic retinopathy.

T Bek1.   

Abstract

Twenty areas of retinal vascular occlusion from ten eyes of 6 diabetic patients were studied by immunohistochemistry to type IV collagen (basement membranes), von Willebrand factor (endothelial cells), and to glial fibrillary acid protein (glial cells) on serial sections. In all studied lesions immunoreactivity to type IV collagen and von Willebrand factor was confined to the retinal vascular walls whereas the material accumulated to occlude the vascular lumens centrally displayed immunoreactivity to glial fibrillary acid protein. All arterioles observed in the lesions were occluded. These arterioles had retained their circular shape, and the intravascular glial protein immunoreactivity communicated with the extravascular glial tissue through localised breaks in the vascular wall. The intravascular immunoreactivity was found to continue inside the arteriole along its successive diminishing to reach the capillary level. The venules were only occluded in less than half of the studied lesions. These venules were collapsed to assume a bean-like shape, and sequences with total obliteration of the vascular lumen alternated with sequences where a residual space corresponding to the former lumen displayed immunoreactivity to glial protein. The paper suggests that glial cell invasion, but not endothelial cells or basement membrane thickening, occludes the vascular lumen in areas of retinal non-perfusion secondary to diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9253965     DOI: 10.1111/j.1600-0420.1997.tb00764.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

Review 1.  Animal models of choroidal and retinal neovascularization.

Authors:  Hans E Grossniklaus; Shin J Kang; Lennart Berglin
Journal:  Prog Retin Eye Res       Date:  2010-05-19       Impact factor: 21.198

Review 2.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

3.  Laws of physics help explain capillary non-perfusion in diabetic retinopathy.

Authors:  E Stefánsson; Y K Chan; T Bek; S H Hardarson; D Wong; D I Wilson
Journal:  Eye (Lond)       Date:  2018-01-19       Impact factor: 3.775

4.  Ocular changes in heredo-oto-ophthalmo-encephalopathy.

Authors:  T Bek
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 5.  Diameter Changes of Retinal Vessels in Diabetic Retinopathy.

Authors:  Toke Bek
Journal:  Curr Diab Rep       Date:  2017-08-08       Impact factor: 4.810

6.  Retinal oxygen saturation changes progressively over time in diabetic retinopathy.

Authors:  Sveinn Hakon Hardarson; Einar Stefánsson; Toke Bek
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

Review 7.  The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.

Authors:  Christine Altmann; Mirko H H Schmidt
Journal:  Int J Mol Sci       Date:  2018-01-01       Impact factor: 5.923

8.  Reduced Oxygen Extraction in the Retinal Periphery When the Arterial Blood Pressure Is Increased by Isometric Exercise in Normal Persons.

Authors:  Toke Bek; Signe Krejberg Jeppesen
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.